Top Endocrinology Research Papers

Overall: This rigorous, highly applicable meta-analysis shows that routine calcium or vitamin D supplementation offers little to no fracture or fall prevention benefit for most community-dwelling adults.

Overall: A large randomized trial supports meaningful kidney and possible survival benefits from semaglutide in a highly relevant primary-care population, though the subgroup design and absent safety information limit certainty about net benefit.

Overall: This large randomized-trial synthesis is clinically influential and directly applicable to US obesity care, but limited head-to-head comparisons, sparse hard-outcome evidence, increased adverse-event discontinuation, and absent absolute effects temper confidence in the net benefit.

Overall: Evolocumab produced credible reductions in major cardiovascular events and mortality among patients with high-risk diabetes, but missing absolute MACE and safety data plus cost and injection burdens temper the net benefit and immediate practice impact.

Overall: This large, precise randomized trial analysis shows a modest absolute but clinically important survival benefit in high-risk patients, with practical impact limited by unreported safety and treatment-burden data.

Overall: A large, methodologically strong systematic review supports remote diabetes care during pregnancy as a practical and generally safe alternative, with possible maternal and neonatal benefits but unresolved absolute effect size, equity, and long-term outcome questions.

Overall: Effect of semaglutide on kidney outcomes in the SELECT, FLOW, and SOUL trials: a prespecified pooled analysis. — Strong pooled randomized evidence shows a precise, moderate reduction in major kidney outcomes with similar overall safety, although absolute benefit and treatment burden are incompletely reported and regimen heterogeneity limits a uniform practice directive.

Overall: A large randomized trial analysis suggests a clinically meaningful and apparently safe reduction in heart failure events with oral semaglutide among high-risk patients with established heart failure, but absent absolute effects and subgroup uncertainty limit immediate practice-changing impact.

Overall: This strong prespecified analysis found clinically meaningful reductions in first cardiovascular events and mortality, but the moderate absolute benefit, injectable treatment burden, and unreported harms temper its immediate impact on primary care.

Overall: This large, long-term US cohort provides precise and clinically relevant support for resistance training in diabetes prevention, but residual confounding and the absence of absolute effects limit causal and practice-changing conclusions.